Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Clinical trial NCT06530576 · RECRUITING
Trial details
- NCT number
- NCT06530576
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-10
- Primary completion
- 2026-06-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.